{"id":12797,"date":"2024-12-20T14:21:19","date_gmt":"2024-12-20T14:21:19","guid":{"rendered":"https:\/\/jubilantbiosys.com\/new-staging\/?page_id=12797"},"modified":"2026-02-22T19:38:53","modified_gmt":"2026-02-22T19:38:53","slug":"virtual-screening","status":"publish","type":"page","link":"https:\/\/www.jubilantbiosys.com\/new-staging\/services\/virtual-screening\/","title":{"rendered":"Virtual Screening"},"content":{"rendered":"\n
\n
\n

Virtual Screening<\/h2>\n<\/div>\n\n\n\n

Using virtual screening, we can help restrict the list of compounds to those that are most likely to have the desired therapeutic effect by screening the compounds based on certain characteristics such as bioactivity, solubility, and toxicity; while drastically cutting down the time and expense associated with the drug development process. Get in touch with our experts to find out how we can assist you.<\/p>\n\n\n\n

Virtual screening of databases of drug-like compounds or target-class-focused libraries is a strategy to discover novel scaffold(s). Virtual screening is a powerful approach to find novel hits, using either structure-based approaches (protein structure or homology model with known\/identified binding site) or ligand-based approaches (chemical structures of known modulators of the target).<\/p>\n<\/div><\/div>\n\n\n\n

\n
\n
\n
Structure-based approaches encompasses<\/h5>\n\n\n\n